Showing results (1151-1160 of 1,211) with videos related to
Sort By:
Pageof 122
Cancers|December 11, 2022
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial GroupGautier Marcq, Luca Afferi, Yann Neuzillet, et al.Cancer|September 25, 2014
Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective studyJorge J Castillo, Mark Bower, Jérémy Brühlmann, et al.Malaria Journal|October 15, 2025
POST introduction evaluation (PIE) of the malaria vaccine introduced in three pilot countries (Ghana, Kenya, and Malawi) in 2021Jenny A Walldorf, Gillian F Mayers, Kwame Amponsa-Achiano, et al.NPJ Digital Medicine|June 2, 2026
Human expertise or artificial intelligence? A prospective study on nail disorder diagnosisFlurin L Brand, Ali Mokhtari, Simone Cazzaniga, et al.Archives of Internal Medicine|May 28, 2003
A prospective trial of structured treatment interruptions in human immunodeficiency virus infectionCatherine Fagard, Annette Oxenius, Huldrych Günthard, et al.Translational Lung Cancer Research|May 20, 2021
Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologistsMarkus Glatzer, Pawel Leskow, Francesca Caparrotti, et al.Frontiers in Pharmacology|December 2, 2024
Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIVPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.Clinical Pharmacology and Therapeutics|March 23, 2024
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIVPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.BMC Infectious Diseases|October 11, 2024
Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort StudyKatharina Kusejko, Roger D Kouyos, Enos Bernasconi, et al.Plos One|October 25, 2024
HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983-2015Andrew Atkinson, David Kraus, Nicolas Banholzer, et al.Pageof 122